ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
62,941.97
0.08%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. PaxMedica Inc (PXMD)

  7. PaxMedica Inc (PXMD) Noticias

PXMD PaxMedica Inc

0.6883
0.00 (0.00%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
PaxMedica Inc PXMD NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 0.6883 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.6883 0.6883
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/4/202407:30GLOBEPaxMedica's CEO and Malawi Health Official Discuss Urgent..
23/4/202407:30GLOBEPaxMedica Responds to Emergency Request for IV Suramin and..
16/4/202415:30GLOBEPaxMedica Receives Emergency Request for IV Suramin from..
11/4/202415:30GLOBEPaxMedica Achieves Key Milestone in the Development of..
13/3/202407:20GLOBEPaxMedica Updated Company Presentation Highlighting..
11/3/202415:45EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/2/202416:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202419:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202416:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202416:20EDGAR2Form 8-K - Current report
12/1/202416:27EDGAR2Form 8-K - Current report
21/12/202307:00EDGAR2Form 8-K - Current report
30/11/202315:07EDGAR2Form 8-K - Current report
29/11/202315:33EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/11/202315:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202315:05EDGAR2Form 8-K - Current report
22/11/202315:24EDGAR2Form 8-K - Current report
22/11/202315:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202307:51EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
20/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
17/11/202307:00GLOBEPaxMedica Inc. Featured in Syndicated Broadcast Highlighting..
16/11/202315:27EDGAR2Form S-1/A - General form for registration of securities..
09/11/202307:00GLOBEPaxMedica's Chief Medical Officer Discusses FDA Meeting..
09/11/202306:18EDGAR2Form 8-K - Current report
09/11/202305:02EDGAR2Form S-1 - General form for registration of securities under..
02/11/202307:30GLOBEPaxMedica Engages Bourne Partners to Explore Future..
31/10/202307:00GLOBEPaxMedica Acquires Suramin Research Assets from Rediscovery..
30/10/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202315:05EDGAR2Form 8-K - Current report
30/10/202310:30GLOBEPaxMedica Announces 1-for-17 Reverse Stock Split
26/10/202312:51GLOBEPaxMedica's Research on Low Dose Suramin for Autism Spectrum..
18/10/202309:10GLOBEThe Bell2Bell Podcast featuring Howard Weisman, CEO and Buzz..
27/9/202315:05EDGAR2Form 8-K - Current report
11/9/202315:05EDGAR2Form DEF 14A - Other definitive proxy statements
06/9/202315:25EDGAR2Form 8-K - Current report
01/9/202315:33EDGAR2Form PRE 14A - Other preliminary proxy statements
30/8/202315:26EDGAR2Form 144 - Report of proposed sale of securities
30/8/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202315:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202315:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202307:00GLOBEPaxMedica to Present at the H.C. Wainwright 25th Annual..
17/8/202315:05EDGAR2Form 8-K - Current report
16/8/202308:00EDGAR2Form 8-K - Current report
16/8/202307:30GLOBEPaxMedica Appoints David Hough M.D. as Chief Medical Officer

Su Consulta Reciente

NASDAQ
PXMD
PaxMedica
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados